HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT00221416

Aripiprazole for mania symptoms in children and adolescents with bipolarity

About this titleRead the official source — NCT00221416
Medication studyAges 7–18
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 7 years to 18 years. Other eligibility criteria applied.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2005
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
University of Cincinnati
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Not clearly listed
Age range
From 7 Years to 18 Years
Official registry ID
NCT00221416
Official title
Show the full official title

An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Cincinnati, a university.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 7 years to 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies